Research on predictive factors in breast cancer
Research of Predictive Clinical and Biological Parameters in Breast Cancer
This study is trying to find out which clinical and biological factors can help predict how breast cancer patients will do, so they can improve treatment and care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut Paoli-Calmettes Academic / other |
| Locations | 2 sites (Marseille and 1 other locations) |
| Trial ID | NCT01521676 on ClinicalTrials.gov |
What this trial studies
This study investigates the clinical and biological parameters that may predict outcomes in breast cancer patients. It focuses on analyzing genomic, proteomic, and mutation data to identify potential molecular alterations associated with the disease. The approach aims to enhance understanding of breast cancer biology and improve patient management strategies. Participants will undergo assessments to gather relevant predictive data.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with breast cancer.
Not a fit: Patients experiencing emergencies related to their condition may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment strategies for breast cancer patients.
How similar studies have performed: Other studies have shown promise in using predictive factors to improve breast cancer treatment outcomes, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * breast cancer * age \> 18 * signed informed consent Exclusion Criteria: * emergency
Where this trial is running
Marseille and 1 other locations
- Institut Paoli Calmettes — Marseille, France (Recruiting)
- Hôpital Sainte-Musse — Toulon, France (Recruiting)
Study contacts
- Principal investigator: Carole TARPIN, MD — Institut Paoli-Calmettes
- Study coordinator: Dominique GENRE, MD
- Email: drci.up@ipc.unicancer.fr
- Phone: 33491223778
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.